ES2144399T3 - Clonado del adn de virus de anemia de los pollos. - Google Patents
Clonado del adn de virus de anemia de los pollos.Info
- Publication number
- ES2144399T3 ES2144399T3 ES91917088T ES91917088T ES2144399T3 ES 2144399 T3 ES2144399 T3 ES 2144399T3 ES 91917088 T ES91917088 T ES 91917088T ES 91917088 T ES91917088 T ES 91917088T ES 2144399 T3 ES2144399 T3 ES 2144399T3
- Authority
- ES
- Spain
- Prior art keywords
- anemia virus
- cloning
- cav
- virus dna
- chicken anemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000725585 Chicken anemia virus Species 0.000 title 1
- 238000010367 cloning Methods 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 2
- 238000002255 vaccination Methods 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10041—Use of virus, viral particle or viral elements as a vector
- C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
SE HA DESCUBIERTO LA INFORMACION GENETICA RECOMBINANTE (DNA O RNA), QUE COMPRENDE UNA SECUENCIA NUCLEOTIDA ESPECIFICA PARA EL VIRUS DE LA ANEMIA DE LA GALLINA Y EL USO DE LA MISMA PARA PRUEBAS DE DIAGNOSTICO, VACUNACION O PRODUCCION DE PROTEINA. ASIMISMO SE PRESNETA LA PROTEINA CAV RECOMBINANTE Y USO DE LA MISMA PARA PRUEBAS DE DIAGNOSTICO, VACUNACION Y PRODUCCION DE ANTICUERPOS ESPECIFICOS PARA EL CAV. ASIMISMO SE PRESENTA EL USO DE LOS ANTICUERPOS ESPECIFICOS PARA EL CAV ASI OBTENIDOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9002008A NL9002008A (nl) | 1990-09-12 | 1990-09-12 | Recombinant dna en rna en daarvan afgeleide produkten. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2144399T3 true ES2144399T3 (es) | 2000-06-16 |
Family
ID=19857669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91917088T Expired - Lifetime ES2144399T3 (es) | 1990-09-12 | 1991-09-11 | Clonado del adn de virus de anemia de los pollos. |
Country Status (21)
Country | Link |
---|---|
US (6) | US5491073A (es) |
EP (2) | EP0548234B1 (es) |
JP (1) | JP2846116B2 (es) |
AT (1) | ATE188739T1 (es) |
AU (1) | AU651999B2 (es) |
CA (1) | CA2091181C (es) |
DE (1) | DE69131903T2 (es) |
DK (1) | DK0548234T3 (es) |
ES (1) | ES2144399T3 (es) |
GR (1) | GR3033173T3 (es) |
HR (1) | HRP940668B1 (es) |
HU (1) | HU220102B (es) |
IL (1) | IL99435A (es) |
MX (1) | MX9101042A (es) |
NL (1) | NL9002008A (es) |
RU (1) | RU2146292C1 (es) |
SI (1) | SI9111508B (es) |
UA (1) | UA48936C2 (es) |
WO (1) | WO1992004446A1 (es) |
YU (1) | YU49095B (es) |
ZA (1) | ZA917065B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138443A1 (en) * | 1993-03-08 | 2003-07-24 | Noteborn Mathews H.M. | Cloning of chicken anemia virus DNA |
US20080234466A1 (en) * | 1990-09-12 | 2008-09-25 | Noteborn Mathieu H M | Delivery method for the tumor-specific apoptosis-inducing activity of apoptin |
NL9301272A (nl) * | 1993-07-20 | 1995-02-16 | Aesculaap Bv | Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus. |
US20020061296A1 (en) * | 2000-09-08 | 2002-05-23 | Noteborn Mathieu H.M. | Delivery method for the tumor specific apoptosis inducing activity of apoptin |
US5922600A (en) * | 1990-09-12 | 1999-07-13 | Leadd Bv | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
ZA918426B (en) * | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
EP0878546A1 (en) * | 1997-04-15 | 1998-11-18 | Leadd B.V. | A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
US5789567A (en) * | 1994-07-06 | 1998-08-04 | Cornell Research Foundation, Inc. | Chicken infectious anemia virus vaccine |
GB9414888D0 (en) * | 1994-07-23 | 1994-09-14 | Univ Belfast | Method and composition |
CA2221570A1 (en) * | 1995-06-07 | 1996-12-19 | Aesculaap B.V. | Neutralizing conformation epitopes of chicken anemia virus |
US6127115A (en) * | 1995-11-14 | 2000-10-03 | Ragland; William L. | Efficient method of detecting an infectious agent in blood |
CZ299874B6 (cs) | 1997-08-12 | 2008-12-17 | Leadd B. V. | Zpusob urcení transformacní schopnosti cinidel, zpusob urcení predispozice bunky, zpusob zjištení genové mutace, použití nukleové kyseliny kódující apoptin a diagnostická testovací souprava |
EP1064024A4 (en) * | 1998-03-13 | 2005-04-06 | Univ Georgia Res Found | VACCINES AGAINST CIRCOVIRUS INFECTIONS |
EP1083224B1 (en) * | 1999-09-02 | 2006-12-06 | Leadd B.V. | Apoptin-associating protein |
AU784723B2 (en) * | 1999-12-10 | 2006-06-01 | Leadd B.V. | Apoptin-associating protein |
US6593134B1 (en) | 2000-03-10 | 2003-07-15 | Cornell Research Foundation, Inc. | Method of propagating chicken infectious anemia virus |
DE60144497D1 (de) * | 2000-07-10 | 2011-06-01 | Uni Charm Corp | Gegenstand zum Reinigen |
EP1199363A1 (en) * | 2000-10-20 | 2002-04-24 | Leadd B.V. | Phosphorylation modifications of apoptin |
CA2477811A1 (en) * | 2001-09-05 | 2003-03-13 | Biomune | Chicken anemia virus vaccine from cell line |
US7566548B2 (en) * | 2004-08-13 | 2009-07-28 | University Of Massachusetts | Methods for identifying therapeutic agents and for treating disease |
CN102636646A (zh) * | 2012-05-15 | 2012-08-15 | 扬州大学 | 快速检测禽白血病抗原的试纸条及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2042888B (en) | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
JPS6034925B2 (ja) | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
JPS6032714A (ja) | 1983-08-01 | 1985-02-19 | Teijin Ltd | 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物 |
DE3583799D1 (de) | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5059587A (en) | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US5079005A (en) | 1988-06-17 | 1992-01-07 | Gupta Kashmiri L | Time release protein |
AU633272B2 (en) * | 1988-09-13 | 1993-01-28 | Merial | Viral nucleotide sequences |
GB2237510B (en) | 1989-11-04 | 1993-09-15 | Danbiosyst Uk | Small particle drug compositions for nasal administration |
US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
ZA918426B (en) | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
-
1990
- 1990-09-12 NL NL9002008A patent/NL9002008A/nl not_active Application Discontinuation
-
1991
- 1991-09-05 ZA ZA917065A patent/ZA917065B/xx unknown
- 1991-09-06 IL IL99435A patent/IL99435A/en not_active IP Right Cessation
- 1991-09-11 JP JP3517451A patent/JP2846116B2/ja not_active Expired - Fee Related
- 1991-09-11 EP EP91917088A patent/EP0548234B1/en not_active Expired - Lifetime
- 1991-09-11 SI SI9111508A patent/SI9111508B/sl unknown
- 1991-09-11 AT AT91917088T patent/ATE188739T1/de not_active IP Right Cessation
- 1991-09-11 DK DK91917088T patent/DK0548234T3/da active
- 1991-09-11 CA CA002091181A patent/CA2091181C/en not_active Expired - Lifetime
- 1991-09-11 RU RU93005170A patent/RU2146292C1/ru not_active IP Right Cessation
- 1991-09-11 AU AU86580/91A patent/AU651999B2/en not_active Ceased
- 1991-09-11 WO PCT/NL1991/000165 patent/WO1992004446A1/en active IP Right Grant
- 1991-09-11 EP EP98202968A patent/EP0905246A1/en not_active Withdrawn
- 1991-09-11 UA UA93004515A patent/UA48936C2/uk unknown
- 1991-09-11 DE DE69131903T patent/DE69131903T2/de not_active Expired - Lifetime
- 1991-09-11 US US08/030,335 patent/US5491073A/en not_active Expired - Lifetime
- 1991-09-11 ES ES91917088T patent/ES2144399T3/es not_active Expired - Lifetime
- 1991-09-11 YU YU150891A patent/YU49095B/sh unknown
- 1991-09-11 HU HU9300716A patent/HU220102B/hu not_active IP Right Cessation
- 1991-09-11 MX MX9101042A patent/MX9101042A/es unknown
-
1994
- 1994-10-12 HR HR940668A patent/HRP940668B1/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/484,939 patent/US6319693B1/en not_active Expired - Fee Related
- 1995-06-07 US US08/480,020 patent/US5932476A/en not_active Expired - Fee Related
-
1997
- 1997-08-13 US US08/910,618 patent/US5958424A/en not_active Expired - Fee Related
- 1997-08-13 US US08/910,322 patent/US6238669B1/en not_active Expired - Fee Related
-
1999
- 1999-08-27 US US09/384,472 patent/US6509446B2/en not_active Expired - Fee Related
-
2000
- 2000-04-07 GR GR20000400866T patent/GR3033173T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2144399T3 (es) | Clonado del adn de virus de anemia de los pollos. | |
ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
DE69835143D1 (de) | Selektion von proteinen mittels rns-protein fusionen | |
DK84194A (da) | Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn | |
ES2059361T3 (es) | Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso. | |
ITTO950367A0 (it) | Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti. | |
BR9811039A (pt) | Citocina de mamìferos: interleucina-b30 e reagentes relacionados | |
ES2061500T3 (es) | Diagnosis y vacunas de la hepatitis delta su preparacion y uso. | |
DE68927025D1 (de) | HIV-2-Virusvarianten | |
RU93005170A (ru) | Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител | |
KR910012244A (ko) | 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도 | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
ATE70280T1 (de) | Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen. | |
AR022236A1 (es) | Citoquinas mamiferas purificadas; reactivos y metodos relacionados | |
ATE175119T1 (de) | Vakzine gegen immunodefizienz-virus der katze (kiv) | |
DE69840445D1 (de) | Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv | |
AR022237A1 (es) | Citoquinas mamiferas purificadas; reactivos y metodos relacionados | |
ES2054769T3 (es) | Polipeptidos hiv-2 recombinantes. | |
ATE180489T1 (de) | Für leberzellkarzinom spezifisches onkogen | |
ATE389018T1 (de) | Cx3c chemokin-gene von säugetieren | |
DE69728897D1 (de) | Saeugetierchemokine | |
ATE346087T1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
ATE294237T1 (de) | S?ugetier thymokingene | |
ATE134878T1 (de) | Impfstoffe gegen metazoen-parasiten | |
ES2074422T3 (es) | Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 548234 Country of ref document: ES |